A citation-based method for searching scientific literature

Kenneth Offit. Hum Genet 2011
Times Cited: 104







List of co-cited articles
418 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
154
9



PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.
Nazneen Rahman, Sheila Seal, Deborah Thompson, Patrick Kelly, Anthony Renwick, Anna Elliott, Sarah Reid, Katarina Spanova, Rita Barfoot, Tasnim Chagtai,[...]. Nat Genet 2007
670
6

The path to personalized medicine.
Margaret A Hamburg, Francis S Collins. N Engl J Med 2010
996
6

Cancer genomics: from discovery science to personalized medicine.
Lynda Chin, Jannik N Andersen, P Andrew Futreal. Nat Med 2011
349
5

Personalized medicine: progress and promise.
Isaac S Chan, Geoffrey S Ginsburg. Annu Rev Genomics Hum Genet 2011
149
5

Effect of direct-to-consumer genomewide profiling to assess disease risk.
Cinnamon S Bloss, Nicholas J Schork, Eric J Topol. N Engl J Med 2011
352
5

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
883
5

Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?
Susan M Domchek, Angela Bradbury, Judy E Garber, Kenneth Offit, Mark E Robson. J Clin Oncol 2013
163
5

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
5


EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.
J Guillermo Paez, Pasi A Jänne, Jeffrey C Lee, Sean Tracy, Heidi Greulich, Stacey Gabriel, Paula Herman, Frederic J Kaye, Neal Lindeman, Titus J Boggon,[...]. Science 2004
4

Genomics, health care, and society.
Kathy L Hudson. N Engl J Med 2011
81
4

Finding the missing heritability of complex diseases.
Teri A Manolio, Francis S Collins, Nancy J Cox, David B Goldstein, Lucia A Hindorff, David J Hunter, Mark I McCarthy, Erin M Ramos, Lon R Cardon, Aravinda Chakravarti,[...]. Nature 2009
4

Letting the genome out of the bottle--will we get our wish?
David J Hunter, Muin J Khoury, Jeffrey M Drazen. N Engl J Med 2008
261
4

Genome-wide association studies of cancer.
Zsofia K Stadler, Peter Thom, Mark E Robson, Jeffrey N Weitzel, Noah D Kauff, Karen E Hurley, Vincent Devlin, Bert Gold, Robert J Klein, Kenneth Offit. J Clin Oncol 2010
113
4

Rare mutations in XRCC2 increase the risk of breast cancer.
D J Park, F Lesueur, T Nguyen-Dumont, M Pertesi, F Odefrey, F Hammet, S L Neuhausen, E M John, I L Andrulis, M B Terry,[...]. Am J Hum Genet 2012
123
4

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
885
4

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.
Anita Villani, Uri Tabori, Joshua Schiffman, Adam Shlien, Joseph Beyene, Harriet Druker, Ana Novokmet, Jonathan Finlay, David Malkin. Lancet Oncol 2011
259
4

Social networkers' attitudes toward direct-to-consumer personal genome testing.
Amy L McGuire, Christina M Diaz, Tao Wang, Susan G Hilsenbeck. Am J Bioeth 2009
154
4

Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
Paul B Chapman, Axel Hauschild, Caroline Robert, John B Haanen, Paolo Ascierto, James Larkin, Reinhard Dummer, Claus Garbe, Alessandro Testori, Michele Maio,[...]. N Engl J Med 2011
4

Revealing the incidentalome when targeting the tumor genome.
Yvonne Bombard, Mark Robson, Kenneth Offit. JAMA 2013
47
8

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
Antonis C Antoniou, Jonathan Beesley, Lesley McGuffog, Olga M Sinilnikova, Sue Healey, Susan L Neuhausen, Yuan Chun Ding, Timothy R Rebbeck, Jeffrey N Weitzel, Henry T Lynch,[...]. Cancer Res 2010
132
4

Performance of common genetic variants in breast-cancer risk models.
Sholom Wacholder, Patricia Hartge, Ross Prentice, Montserrat Garcia-Closas, Heather Spencer Feigelson, W Ryan Diver, Michael J Thun, David G Cox, Susan E Hankinson, Peter Kraft,[...]. N Engl J Med 2010
325
4

Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
Kyriaki Michailidou, Per Hall, Anna Gonzalez-Neira, Maya Ghoussaini, Joe Dennis, Roger L Milne, Marjanka K Schmidt, Jenny Chang-Claude, Stig E Bojesen, Manjeet K Bolla,[...]. Nat Genet 2013
794
4

What is personalized medicine: sharpening a vague term based on a systematic literature review.
Sebastian Schleidgen, Corinna Klingler, Teresa Bertram, Wolf H Rogowski, Georg Marckmann. BMC Med Ethics 2013
119
4

Biobanking in a fast moving world: an international perspective.
Robert Hewitt, Pierre Hainaut. J Natl Cancer Inst Monogr 2011
26
11



Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.
John S Welch, Peter Westervelt, Li Ding, David E Larson, Jeffery M Klco, Shashikant Kulkarni, John Wallis, Ken Chen, Jacqueline E Payton, Robert S Fulton,[...]. JAMA 2011
171
3

Inhibition of mutated, activated BRAF in metastatic melanoma.
Keith T Flaherty, Igor Puzanov, Kevin B Kim, Antoni Ribas, Grant A McArthur, Jeffrey A Sosman, Peter J O'Dwyer, Richard J Lee, Joseph F Grippo, Keith Nolop,[...]. N Engl J Med 2010
3

International network of cancer genome projects.
Thomas J Hudson, Warwick Anderson, Axel Artez, Anna D Barker, Cindy Bell, Rosa R Bernabé, M K Bhan, Fabien Calvo, Iiro Eerola, Daniela S Gerhard,[...]. Nature 2010
3

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.
Thomas J Lynch, Daphne W Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A Okimoto, Brian W Brannigan, Patricia L Harris, Sara M Haserlat, Jeffrey G Supko, Frank G Haluska,[...]. N Engl J Med 2004
3

Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and “personalized” medicine?
Wylie Burke, Hilary Burton, Alison E Hall, Mohamed Karmali, Muin J Khoury, Bartha Knoppers, Eric M Meslin, Fiona Stanley, Caroline F Wright, Ronald L Zimmern. Genet Med 2010
61
4

What is the clinical utility of genetic testing?
Scott D Grosse, Muin J Khoury. Genet Med 2006
182
3


A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer.
Christopher A Haiman, Gary K Chen, Celine M Vachon, Federico Canzian, Alison Dunning, Robert C Millikan, Xianshu Wang, Foluso Ademuyiwa, Shahana Ahmed, Christine B Ambrosone,[...]. Nat Genet 2011
237
3

Systems biology: Metabonomics.
Jeremy K Nicholson, John C Lindon. Nature 2008
3

Gene-environment interactions in human diseases.
David J Hunter. Nat Rev Genet 2005
627
3

Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.
Alan R Shuldiner, Jeffrey R O'Connell, Kevin P Bliden, Amish Gandhi, Kathleen Ryan, Richard B Horenstein, Coleen M Damcott, Ruth Pakyz, Udaya S Tantry, Quince Gibson,[...]. JAMA 2009
3

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.
Hanne Meijers-Heijboer, Ans van den Ouweland, Jan Klijn, Marijke Wasielewski, Anja de Snoo, Rogier Oldenburg, Antoinette Hollestelle, Mark Houben, Ellen Crepin, Monique van Veghel-Plandsoen,[...]. Nat Genet 2002
791
3

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.
Alfons Meindl, Heide Hellebrand, Constanze Wiek, Verena Erven, Barbara Wappenschmidt, Dieter Niederacher, Marcel Freund, Peter Lichtner, Linda Hartmann, Heiner Schaal,[...]. Nat Genet 2010
476
3

Genomics and drug response.
Liewei Wang, Howard L McLeod, Richard M Weinshilboum. N Engl J Med 2011
381
3

Predictive, personalized, preventive, participatory (P4) cancer medicine.
Leroy Hood, Stephen H Friend. Nat Rev Clin Oncol 2011
363
3

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index.
Elizabeth K Speliotes, Cristen J Willer, Sonja I Berndt, Keri L Monda, Gudmar Thorleifsson, Anne U Jackson, Hana Lango Allen, Cecilia M Lindgren, Jian'an Luan, Reedik Mägi,[...]. Nat Genet 2010
3

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake,[...]. Proc Natl Acad Sci U S A 2011
623
3

A computational method to classify variants of uncertain significance using functional assay data with application to BRCA1.
Edwin S Iversen, Fergus J Couch, David E Goldgar, Sean V Tavtigian, Alvaro N A Monteiro. Cancer Epidemiol Biomarkers Prev 2011
38
7

Genetic testing in Li-Fraumeni syndrome: uptake and psychosocial consequences.
Chantal R M Lammens, Neil K Aaronson, Anja Wagner, Rolf H Sijmons, Margreet G E M Ausems, Annette H J T Vriends, Mariëlle W G Ruijs, Theo A M van Os, Liesbeth Spruijt, Encarna B Gómez García,[...]. J Clin Oncol 2010
73
4

A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS).
Noralane M Lindor, Lucia Guidugli, Xianshu Wang, Maxime P Vallée, Alvaro N A Monteiro, Sean Tavtigian, David E Goldgar, Fergus J Couch. Hum Mutat 2012
154
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.